Skip to content
OpenCapital
Get started

vTv Therapeutics VTVT Q4 2025 Annual earnings

Reported March 10, 2026 · Before market open

Diluted EPS-$0.58Beat by $0.40
EPS estimate-$0.98

Next report

Aug 11, 2026 (In 4 weeks)
Revenue estimate$333.3K
EPS estimate-$0.97

Versus estimates

Revenue

Q1 2026$36.8MBeat by $16.8MQ4 2024$17.0K

Diluted EPS

Q1 2026$1.65Beat by $1.31
Q4 2025-$0.58Beat by $0.40
Q3 2025-$1.08Miss by $0.11Q2 2025-$0.92Miss by $0.07Q1 2025-$0.77Miss by $0.04Q4 2024-$0.55Beat by $0.32

Ask the moment vTv Therapeutics reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did vTv Therapeutics report Q4 2025 earnings?
vTv Therapeutics (VTVT) reported Q4 2025 earnings on March 10, 2026 before market open.
What were vTv Therapeutics's Q4 2025 revenue and EPS?
vTv Therapeutics reported diluted EPS of $-0.58 for Q4 2025.
Did vTv Therapeutics beat estimates in Q4 2025?
EPS beat the consensus estimate of $-0.98 by $0.40.
How did vTv Therapeutics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 5.5% from $-0.55.
Where can I find vTv Therapeutics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001641489-26-000011) and the 10-K periodic report (0001641489-26-000010) directly on SEC EDGAR. The filing index links above go to sec.gov.